CSIMarket
 
Tactile Systems Technology Inc   (TCMD)
Other Ticker:  
 
 
Price: $15.8350 $-0.92 -5.463%
Day's High: $16.75 Week Perf: -0.6 %
Day's Low: $ 15.83 30 Day Perf: 3.63 %
Volume (M): 273 52 Wk High: $ 26.11
Volume (M$): $ 4,325 52 Wk Avg: $17.00
Open: $16.75 52 Wk Low: $9.69



 Market Capitalization (Millions $) 367
 Shares Outstanding (Millions) 23
 Employees 858
 Revenues (TTM) (Millions $) 274
 Net Income (TTM) (Millions $) 29
 Cash Flow (TTM) (Millions $) 39
 Capital Exp. (TTM) (Millions $) 2

Tactile Systems Technology Inc
Tactile Systems Technology Inc. is a publicly traded medical device company focused on developing and marketing at-home therapy devices that improve circulation and reduce swelling, discomfort and pain for individuals with lymphedema, chronic venous insufficiency, and other conditions affecting the lymphatic and vascular systems.

Headquartered in Minneapolis, Minnesota, the company was founded in 1995 by a licensed physical therapist, and to date, it has continued to develop clinically proven, non-invasive, and cost-effective products that aid in the management of chronic diseases. Tactile Systems Technology primarily markets its products through direct sales and a network of distributors across the United States as well as partnering with healthcare professionals such as lymphedema and wound care therapists.

One of their primary products, the Flexitouche system, utilizes a pneumatic compression technology to simulate the hand motion of a lymphatic therapist or clinician performing various stages of manual lymph drainage. It is indicated for the treatment of lymphedema in the arms, legs or trunk, and has been clinically demonstrated to reduce swelling, increase limb mobility and reduce the risk of infection. Another product, the Entr' System, is a simplified and portable version of the Flexitouche system, and is intended for use by patients and caregivers in the home environment.

Tactile Systems Technology has a strong commitment to research and development, and as a result, the company has obtained multiple patents for its innovative technology. The company also collaborates with leading healthcare professionals and institutions to conduct research studies aimed at improving the quality of life for patients with chronic diseases.

In addition, Tactile Systems Technology has received numerous accolades and recognitions for its outstanding contribution to the medical device industry. These include being named Forbes' "Top 100 Public Companies in America" and "Top Small Cap Growth Companies" along with various industry awards, such as the "2017 Global Frost & Sullivan Award for Growth Excellence Leadership" in the compression therapy industry.

Overall, Tactile Systems Technology's mission is to improve the lives of individuals living with chronic diseases based on its strong belief in the power of science, innovation and committed partnership with patients, healthcare professionals and the community.


   Company Address: 3701 Wayzata Blvd, Suite 300 Minneapolis 55416 MN
   Company Phone Number: 355-5100   Stock Exchange / Ticker: NASDAQ TCMD
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Tactile Systems Technology Inc

Tactile Systems Technology Inc Reports 5.046% Rise in Revenue for Q4 2023 Period



Tactile Systems Technology Inc, a prominent Medical Equipment & Supplies company, recently released its financial results for the October to December 31, 2023 period. The company reported improved profit margins and a significant increase in net earnings. However, while revenue grew compared to the previous reporting period, it fell short when compared to the industry average. This article aims to analyze the financial highlights while providing a contextual evaluation of Tactile Systems Technology Inc's performance.
Financial Analysis:
1. Earnings per Share (EPS): Tactile Systems Technology Inc's profit per share for Q4 2023 increased by 30.65% to $0.29 from $0.22 per share in the previous year. However, EPS dropped by -68.76% to $0.94 per share compared to the prior reporting period.

Tactile Systems Technology Inc

Tactile Systems Surges: $14.71 Million Boosted Earnings Thanks to Strategic Provisions on Income Taxes

Tactile Systems Technology Inc: Impressive Financial Performance Fuels Investor Confidence
Tactile Systems Technology Inc, a leading player in the Medical Equipment & Supplies industry, has recently released its financial results for the period ending September 30, 2023. The company reported positive earnings per share (EPS) of $0.94, a significant improvement compared to the negative EPS of $-0.11 reported a year prior. This upward trajectory is even more impressive when considering that the company had no earnings from the preceding reporting period.
One of the driving factors behind Tactile Systems Technology Inc's success is its remarkable revenue growth. The company's revenue increased by an impressive 6.278% to $69.36 million, up from $65.26 million in the corresponding period a year before. Furthermore, the company experienced a sequential revenue growth of 1.552% from $68.30 million.

Tactile Systems Technology Inc

Phenomenal Revenue Boost for Tactile Systems Technology Inc Amid 2023's Second Quarter Earnings Season

Tactile Systems Technology Inc. (Tactile) is a medical technology company that specializes in developing and providing innovative medical devices for the treatment of lymphedema and chronic venous insufficiency. The company's products are designed to improve patient outcomes and enhance the quality of life for individuals suffering from these conditions.
In the fiscal interval ending June 30, 2023, Tactile Systems Technology Inc. reached a break-even of $0.00 per share, a significant improvement compared to the previous year's loss of $0.23 per share. Additionally, this marked an increase from the prior reporting period, where the company reported a loss of $0.09 per share. This positive development in earnings reflects the company's efforts to improve its financial performance and become more profitable.

Tactile Systems Technology Inc

Tactile Systems Technology Inc Reports Surge in Revenue, but Struggles with Deficit of $-0.09 per Share in Q1 2023

Tactile Systems Technology Inc is a medical equipment and supplies company that specializes in developing and manufacturing devices for the treatment of chronic swelling conditions such as lymphedema. Founded in 1995, Tactile Systems utilizes innovative technology to improve the quality of life for patients suffering from these conditions.
Recently, the company announced a significant surge in revenue for the fiscal time-frame ending March 31, 2023. Tactile Systems reported an increase of 22.652% in revenue to $58.85 million compared to the same quarter the previous year. However, the company also reported a net deficit of $-1.886 million for the quarter, indicating that the increased revenue did not translate into profit for the company.






 

Tactile Systems Technology Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Tactile Systems Technology Inc does not provide revenue guidance.

Earnings Outlook
Tactile Systems Technology Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com